Current Opinion in Virology

Papers
(The TQCC of Current Opinion in Virology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board51
A novel antiviral strategy by disrupting the equilibrium of virus-host calcium homeostasis50
Inhaled aerosol viral-vectored vaccines against tuberculosis38
Transmission patterns of hepatitis E virus35
Hepatitis-B virus: replication cycle, targets, and antiviral approaches35
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-1934
The enigmatic roles of Anelloviridae and Redondoviridae in humans34
Colonization of peripheral ganglia by herpes simplex virus type 1 and 231
Human placental models for studying viral infections30
Editorial Board30
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs27
Editorial overview: Viral pathogenesis25
Editorial Board24
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation23
Emerging technologies in the study of the virome23
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface22
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity20
A review of broadly protective monoclonal antibodies to treat Ebola virus disease20
A complex immune communication between eicosanoids and pulmonary macrophages20
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?19
Asymmetry in icosahedral viruses19
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?18
Editorial Board18
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities18
Retasking of canonical antiviral factors into proviral effectors17
Human organoid models to study coronavirus infections of the respiratory tract17
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases17
Tissue-resident memory T cells in protective immunity to influenza virus17
Hemagglutinin stability as a key determinant of influenza A virus transmission via air17
Oncogenic Animal Herpesviruses17
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity17
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection16
Role of the viral polymerase during adaptation of influenza A viruses to new hosts16
Deimmunization of flagellin adjuvant for clinical application16
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions16
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications16
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 515
Diagnosis and monitoring of virus-associated cancer using cell-free DNA15
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy15
0.46364378929138